Pediatrics Doctors in Ridgefield, CT Accepting Medicare
8 Pediatrics doctors found. Showing 1 - 8
 Dr. Joanne Angiello, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38b Grove Street, Ridgefield Pediatric Associates, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
 Mr. Robert Myron Elisofon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38 B Grove St, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
Dr. Dennis O'brien, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 900 Ridgebury Rd, Ridgefield, CT 06877 Phone: 203-791-6466 |
Jane M Brotanek, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38b Grove Street, Ridgefield Pediatric Associates, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
Ms. Carol Fares Boland, APRN Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38b Grove St, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
Dr. John Louis Costa, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3 Ginos Way, Ridgefield, CT 06877 Phone: 203-244-5500 |
Dr. Anil J Britto, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38b Grove St, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
Dr. Karen P Nordberg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 38b Grove St, Ridgefield, CT 06877 Phone: 203-438-9557 Fax: 203-438-7857 |
News Archive
Effective, safe care depends on coordination across primary and secondary healthcare service levels
The Norwegian healthcare services are organized in primary and secondary service levels. According to PhD student Kristin Laugaland at UiS effective and safe care depends on coordination across the two service levels in which transitions across them represent a crucial stage in the recovery of elderly people.
Positive results from Alnylam's ALN-PCS Phase I trial on severe hypercholesterolemia
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive results from its Phase I clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
Blocking APE1 enzyme could provide new way to kill cancer cells
BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
After January renomination, a hearing for Tavenner appears likely
The Washington Post inteviewed the Obama administration's pick to head the Centers for Medicare & Medicaid Services.
› Verified 1 days ago
Internal Medicine
Family Medicine
Pediatrics
Psychiatry & Neurology
Infectious Disease
Ophthalmology
Gastroenterology
General Practice
Plastic Surgery
Preventive Medicine
Cardiovascular Disease